The stock of Elevance Health Inc (ELV) is currently priced at $277.09. In the last session, the stock climbed significantly, topping out at $585.0 after opening at $277.09. The day’s lowest price was $428.0 before the stock closed at $302.45.
Elevance Health Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $567.26 on 09/03/24, while the lowest value for the same period was recorded at $296.39 on 07/18/25.
52-week price history of ELV Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Elevance Health Inc’s current trading price is -51.15% away from its 52-week high, while its distance from the 52-week low is -6.51%. The stock’s price range during this period has spanned from $296.39 to $567.26. In the Healthcare sector, the Elevance Health Inc’s shares surpassed a trading volume of approximately 8.37 million for the day, which was noticeably higher compared to the average daily volume of 9.1.87 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Elevance Health Inc (ELV) has experienced a quarterly decline of -36.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 62.39B and boasts a workforce of 104200 employees.
A Closer Look at Analysts’ Ratings for Elevance Health Inc
As of right now, 13 analysts are rating Elevance Health Inc as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 397.61, with a change in price of -108.17. Similarly, Elevance Health Inc recorded 1,921,496 in trading volume during the last 100 days, posting a change of -28.08%.
Examining ELV’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ELV stands at 0.69. Similarly, the long-term debt-to-equity ratio is also 0.64.
ELV Stock Stochastic Average
Today, Elevance Health Inc’s raw stochastic average for the past 50 days stands at 0.46%, indicating a decline from the raw stochastic average of the last 20 days, which was 0.54%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 6.91% and 7.32% respectively.
ELV Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -49.91% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -28.82%. Over the past 30 days, the price of ELV has leaped by -26.15%. And in the last five days, it has fallen by -18.66%.
